Integra Lifesciences Holdings (IART) Interest & Investment Income (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Interest & Investment Income of $4.3 million for Q2 2026, up 3.92% sequentially from $4.1 million in Q1 2026, and down 9.41% YoY from $4.7 million in Q2 2025.
Integra Lifesciences Holdings (IART) Interest & Investment Income (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Interest & Investment Income for 18 years, with the latest figure at $4.3 million in Q2 2026.
- Quarterly Interest & Investment Income fell 9.41% year-over-year to $4.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $17.7 million (down 7.1% YoY) and the FY2025 annual result came in at $18.5 million, down 7.81% from the prior year.
- Interest & Investment Income climbed to $4.3 million in Q2 2026 per IART's latest filing, from $4.1 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $5.3 million in Q4 2022 and troughed at $1.4 million in Q1 2022.
- A 5-year average of $4.2 million and a median of $4.5 million in 2023 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 269.08% in 2022, down 21.22% in 2022.
- Over 5 years, Interest & Investment Income stood at $5.3 million in 2022, then declined by 14.35% to $4.5 million in 2023, then rose by 7.56% to $4.9 million in 2024, then dropped by 10.85% to $4.4 million in 2025, then slipped by 2.18% to $4.3 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $4.3 million, $4.1 million, and $4.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | - |
| 10 | Integra Lifesciences Holdings | 1.32 Bn | 1.05 Bn | 219.74 Mn | 4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.27 Mn |
| Mar 31, 2026 | 4.11 Mn |
| Dec 31, 2025 | 4.36 Mn |
| Sep 30, 2025 | 4.98 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 4.42 Mn |
| Dec 31, 2024 | 4.89 Mn |
| Sep 30, 2024 | 5.05 Mn |
| Jun 30, 2024 | 5.06 Mn |
| Mar 31, 2024 | 5.04 Mn |
| Dec 31, 2023 | 4.55 Mn |
| Sep 30, 2023 | 4.61 Mn |
| Jun 30, 2023 | 3.94 Mn |
| Mar 31, 2023 | 4.11 Mn |
| Dec 31, 2022 | 5.31 Mn |
| Sep 30, 2022 | 3.26 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.79 Mn |